(Circulation. 1997;95:1745-1748.)
© 1997 American Heart Association, Inc.
Articles |
the Krannert Institute of Cardiology, Department of Medicine, Indiana University School of Medicine, and the Roudebush Veterans Administration Medical Center, Indianapolis, Ind.
Correspondence to Douglas P. Zipes, MD, Krannert Institute of Cardiology, 1111 W 10th St, Indianapolis, IN 46202-4800.
Key Words: Editorials atrium ventricles arrhythmia fibrillation
| Introduction |
|---|
|
|
|---|
| Effects of Prolonged Tachycardia on Ventricular Electrophysiology |
|---|
|
|
|---|
In pigs subjected to 3 weeks of a tachycardia-induced cardiomyopathy, myocyte action potential showed reduced membrane resting potential, reduced amplitude and upstroke velocity, and prolonged duration at 90% repolarization. Peak L-type Ca2+ current density was reduced because of an absolute reduction in L-type Ca2+ current flow into the myocyte possibly caused by reduced open probability of the channel.8 However, in dogs that had rapid ventricular pacing for 3 to 4 weeks, action potential duration was prolonged at least in part because of downregulation of Ito. Basal L-type Ca2+ current and whole-cell Na+ current did not differ in cells from control and failing hearts.9 Species differences and the ionic heterogeneity in the ventricular myocardium may help explain the different results from these two studies.
| Effect of Transient Tachycardia on Ventricular Electrophysiology |
|---|
|
|
|---|
There may be clinical correlates to these laboratory observations. For example, if the patient with atrial fibrillation experiences torsade de pointes because of the acquired long-QT syndrome when treated with a drug like quinidine, he or she usually does so at the return of sinus rhythm, presumably when the rate suddenly slows.12 A second example is the patient who develops torsade de pointes soon after the sudden initiation of complete AV block by radiofrequency catheter ablation.13
| Effect of Prolonged Tachycardia on Atrial Electrophysiology |
|---|
|
|
|---|
After prolonged pacing-induced atrial fibrillation, the previously normal atrium now maintains stable sustained atrial fibrillation.14 15 16 This may result, at least in part, because the abbreviated atrial refractory period leads to shortening of the wavelength of the reentrant wavelets responsible for atrial fibrillation (wavelength is the distance traveled by the depolarization wave front during the duration of its refractory period and equals conduction velocity times refractoriness). A long wavelength may not permit reentry to sustain, causing the fibrillation to terminate, and may be the mechanism by which some drugs abolish atrial fibrillation. A short wavelength would allow a greater number of wavelets to coexist in the atria at one time, making it less likely, according to Moe's multiple wavelet hypothesis, that they will all extinguish simultaneously. The critical number of wavelets to sustain atrial fibrillation in an isolated canine heart is estimated to be four to six.18 Intra-atrial conduction disturbances16 17 would contribute to the maintenance of the atrial fibrillation, as would dispersion of atrial refractoriness. However, the pacing-induced atrial fibrillation model does not appear to increase dispersion of refractoriness, at least when determined at the two atrial appendages and estimated at multiple sites from the median atrial fibrillation interval.14
Studies in humans support the concept of rate-induced remodeling in the atrium by showing that the duration of the atrial monophasic action potential after termination of atrial fibrillation is shortened and that the degree of shortening correlates with the inability to maintain sinus rhythm.19 20 21 The refractory period has also been shown to lose its normal rate adaptation.21
The ionic basis of atrial action potential shortening may be a decrease in Ito and ICa.22 In atrial cells from humans with chronic atrial fibrillation, reduction in outward K+ current density and downregulation of Kv1.5 have been shown.23
Prolonged pacing-induced atrial fibrillation also can provoke anatomic changes in the atria. Biatrial enlargement15 17 and increased mitochondrial size and number with disruption of the sarcoplasmic reticulum15 have been described. An increase in connexin43 has been found in one study, despite development of coexisting intra-atrial conduction delay.17 In another study,24 the expression pattern of connexin43 was unchanged, while connexin40 showed discontinuities between islands of cells but did not appear to affect conduction velocity. Cells also undergo major myolysis and hypertrophy.25
| Effect of Transient Tachycardia on Atrial Electrophysiology |
|---|
|
|
|---|
25 ms after as little as 7 or 8 minutes of pacing-induced atrial fibrillation and facilitated reinduction of atrial fibrillation. Refractoriness returned to control values after about the same time interval.26 In this issue of Circulation, Tieleman et al27 present results in conscious goats subjected to 24 hours of atrial pacing at a cycle length of 200 ms. They found that atrial refractoriness shortened most in the first 4 hours and did so more at slow than fast rates, thus eliminating the normal pattern of physiological rate adaptation. Verapamil blunted the reduction in atrial refractoriness and shortened the time for refractoriness to return to control values; ie, it reduced the time constants for remodeling. With verapamil, no further shortening of refractoriness occurred after 8 hours of rapid pacing, and rate adaptation was still present. Return of refractoriness took <6 hours in the verapamil-treated dogs, whereas it still had not returned to original values in the control dogs. The inducibility of atrial fibrillation correlated with the duration of pacing, but despite a significant reduction in electrical remodeling, verapamil minimally reduced the inducibility of atrial fibrillation.
More Questions Than Answers
Although the above studies have advanced our knowledge about rate-induced electrophysiological remodeling, they raise some very interesting questions. For example, of fundamental importance is the ionic mechanism responsible for the cardiac remodeling of refractoriness. Because of the known effects of rapid rates on intracellular calcium influx and the observation that verapamil blunted the refractory period changes,10 27 one can assume that the L-type calcium channel is probably important in mediating some of the observed changes. Initial studies in atrial cells have shown a decrease in Ito and ICa,22 along with downregulation of Kv1.5.23 In ventricular myocytes, a reduction in L-type Ca2+ current8 and Ito9 have been found. However, other ionic species may also be involved. It is important to stress that the duration and rate of rapid pacing, the animal species, and the particular cells sampled may affect the ionic changes. Further, it is possible that pacing-induced electrophysiological remodeling after just hours or a day or two may represent a "purer" electrophysiological response to the rate intervention than after pacing for 3 to 4 weeks. The latter time course introduces major structural alterations,3 4 5 6 7 15 17 24 25 making it difficult to separate primary from secondary electrophysiological responses.
It is also of interest that both transient rapid ventricular pacing superimposed on a ventricular bradycardia10 and prolonged tachycardia8 9 lengthened the ventricular action potential and refractoriness. However, both transient and prolonged rapid pacing in the atrium or atrial fibrillation shortened atrial action potential duration and refractoriness.14 15 16 17 19 20 21 22 23 26 27 These opposite responses may be caused by differences in the conditions of the experimental protocols and/or tissue type but certainly raise the possibility of different ionic mechanisms for the two chambers despite the fact that a reduction in Ito and L-type Ca2+ current has been shown for both cell types. Whether the refractory period lengthens or shortens naturally could affect the nature of the arrhythmia induced, torsade de pointes in the ventricle, and atrial fibrillation in the atrium.
Although prolongation of refractoriness appears important for initiation of torsade de pointes in the ventricle, just how important shortening of atrial refractoriness is for the development of sustained atrial fibrillation can be questioned. First, verapamil, which blunted the atrial remodeling, had no major impact on atrial fibrillation induction.27 Second, despite major shortening of refractoriness over short time periods in the animal27 and clinical26 studies, sustained atrial fibrillation did not develop. Indeed, prolonged periods of pacing-induced atrial fibrillation are required for this to occur.14 15 16 17 Furthermore, both acute28 and more chronic29 atrial dilation have been shown to prolong atrial refractoriness but still facilitate induction of atrial fibrillation. These observations suggest that other electrophysiological and perhaps structural changes are required for atrial fibrillation to sustain, including atrial dilation,15 17 28 29 changes in mitochondria15 or connexin4317 expression or connexin40 distribution,24 or cell size.25 Depression of sinus node function may be important,16 as may the development of conduction delay in the atrium.16 17 The fact that no change in conduction velocity over Bachmann's bundle has been found14 24 27 but prolongation of P-wave duration and intra-atrial conduction have been noted16 17 evokes the possibility that Bachmann's bundle is relatively impervious to the remodeling stimuli, although other parts of the atrium are not. This naturally raises the very important question of whether remodeling occurs nonuniformly, affecting the crista terminalis, atrial free walls, appendages, sinus node and Bachmann's bundle, or various ventricular cells differently. Exploration of this issue and a more thorough morphological investigation are needed.
| Clinical Application |
|---|
|
|
|---|
| Acknowledgments |
|---|
| Footnotes |
|---|
| References |
|---|
|
|
|---|
2. Whipple GH, Sheffield LT, Woodman EG, Theophilas C, Friedman C. Reversible congestive heart failure due to rapid stimulation of the normal heart. Proc New Engl Cardiovasc Soc. 1962;20:39-40.
3. Spinale FG, Bishop SP. Myocardial remodeling with the development of tachycardia induced heart failure. In: Spinale FG, ed. Pathophysiology of Tachycardia Induced Heart Failure. Armonk, NY: Futura Publishing Co; 1996:61-87.
4. Spinale FG. Myocyte contractile processes with the development of tachycardia induced heart failure. In: Spinale FG, ed. Pathophysiology of Tachycardia Induced Heart Failure. Armonk, NY: Futura Publishing Co; 1996:89-123.
5.
Kajstura J, Zhang X, Liu Y, Szoke E, Cheng W, Olivetti G, Hintze TH, Anversa P. The cellular basis of pacing induced dilated cardiomyopathy: myocyte cell loss and myocyte cellular reactive hypertrophy. Circulation. 1995;92:2306-2317.
6.
Eble DM, Spinale FG. Effects of chronic supraventricular tachycardia on contractile and non-contractile mRNA expression: relation to changes in myocyte structure and function. Am J Physiol. 1995;268:H2426-2439.
7.
Williams RE, Cass DA, Kawagoe Y, Pak P, Tunin RS, Shah R, Hwang A, Feldman AM. Endomyocardial gene expression during the development of pacing tachycardia induced heart failure in the dog. Circ Res. 1994;75:615-623.
8. Mukherjee R, Hewett KW, Spinale FG. Myocyte electrophysiological properties following the development of supraventricular tachycardia induced cardiomyopathy. J Mol Cell Cardiol. 1995;27:1333-1348.[Medline] [Order article via Infotrieve]
9.
Kaab S, Nuss HB, Chiamvimonvat N, O'Rourke B, Pak PH, Kass DA, Marban E, Tomaselli GF. Ionic mechanism of action potential prolongation in ventricular myocytes from dogs with pacing induced heart failure. Circ Res. 1996;78:262-273.
10.
Satoh T, Zipes DP. Rapid rates during bradycardia pacing prolong ventricular refractoriness and facilitate ventricular tachycardia induction with cesium in dogs. Circulation. 1996;94:217-227.
11. Rubart M, Zipes DP. Transient tachycardia superimposed on bradycardia prolongs repolarization in isolated canine ventricular myocytes. J Am Coll Cardiol. 1997;29(suppl A):62A. Abstract.
12. Roden DM, Woosely RL, Primm RK. Incidence and clinical features of the quinidine-associated long QT syndrome: implications for patient care. Am Heart J. 1986;111:1088-1093.[Medline] [Order article via Infotrieve]
13. Brandt RR, Shen W-K. Bradycardia-induced polymorphic ventricular tachycardia after atrioventricular junction ablation for sinus tachycardia-induced cardiomyopathy. J Cardiovasc Electrophysiol. 1995;6:630-633.[Medline] [Order article via Infotrieve]
14.
Wijffels MCEF, Kirchhof CJHJ, Dorland R, Allessie MA. Atrial fibrillation begets atrial fibrillation: a study in awake, chronically instrumented goats. Circulation. 1995;92:1954-1968.
15.
Morillo GA, Klein GJ, Jones DL, Guiradon CM. Chronic rapid atrial pacing: structural, functional, and electrophysiological characteristics of a new model of sustained atrial fibrillation. Circulation. 1995;91:1588-1595.
16.
Elvan A, Zipes DP. Pacing induced chronic atrial fibrillation impairs sinus node function in dogs. Circulation. 1996;94:2953-2960.
17. Elvan A, Huang X, Pressler M, Zipes DP. Radiofrequency catheterablation of the atria eliminates pacing induced sustained atrial fibrillation and reduces connexin43 in dogs. Circulation. In press.
18. Allessie MA. Reentrant mechanisms underlying atrial fibrillation. In: Zipes DP, Jalife J, eds. Cardiac Electrophysiology: From Cell to Bedside. Orlando, Fla: WB Saunders; 1995:562-566.
19. Olsson SB, Cotoi S, Varnauskas E. Monophasic action potential and sinus rhythm stability after conversion of atrial fibrillation. Acta Med Scand. 1971;190:381-387.[Medline] [Order article via Infotrieve]
20. Cotoi S, Gavrilescu S, Pop T, Vicas E. The prognostic value of right atrium monophasic action potential after conversion of atrial fibrillation. Eur J Clin Invest. 1972;2:472-474.[Medline] [Order article via Infotrieve]
21. Attuel P, Childress RW, Cauchemez B, Proveda J, Mugica J, Coumel P. Failure in rate adaptation of the atrial refractory period: its relation to vulnerability. Int J Cardiol. 1982;2:179-197.[Medline] [Order article via Infotrieve]
22. Yue L, Feng J, Gaspo R, Li GR, Nattel S. Ionic remodeling underlying tachycardia-induced atrial fibrillation in dogs. Circulation. 1996;94(suppl I):I-592. Abstract.
23. VanWagoner DR, Pond AL, McCarthy PM, Nerbonne JM. Outward K+ currents and Kv1.5 K+ channels are reduced in chronic human atrial fibrillation. Circulation. 1996;94(suppl I):I-592. Abstract.
24. van der Velden HMW, van Zijverden M, van Kemper MJA, Wijffels MCEF, Groenewegen WA, Allessie MA, Jongsma HG. Abnormal expression of the gap junction protein connexin40 during chronic atrial fibrillation in the goat. Circulation. 1996;94(suppl I):I-593. Abstract.
25. Borders M, Ausma J, Thone F, Wouters L, Wijffels M, Allessie M. Structural changes of atrial myocardium after chronic atrial fibrillation in the goat. Circulation. 1996;94(suppl I):I-593. Abstract.
26.
Daoud EG, Bogun F, Goyal R, Harvey M, Man KC, Strickberger SA, Morady F. Effect of atrial fibrillation on atrial refractoriness in humans. Circulation. 1996;94:1600-1606.
27.
Tieleman RG, DeLangen CDJ, VanGelder IC, deKam PJ, Granjean J, Bell KJ, Wijffels MCEF, Allessie MA, Crijns HJGM. Verapamil reduces tachycardia induced electrical remodeling of the atria. Circulation. 1997;95:1945-1953.
28. Satoh T, Zipes DP. Unequal atrial stretch in dogs increases dispersion of refractoriness conducive to developing atrial fibrillation. J Cardiovasc Electrophysiol. 1996;7:833-842.[Medline] [Order article via Infotrieve]
29. Olgin JE, Kalman JM, Chin M, Stillson C, Karch M, Lesh MD. Role of autonomic tone and atrial size on electrical remodeling in a canine model of atrial fibrillation. Circulation. 1996;94(suppl I):I-352. Abstract.
This article has been cited by other articles:
![]() |
E. G. Manios, E. M. Kallergis, E. M. Kanoupakis, H. E. Mavrakis, H. K. Mouloudi, N. K. Klapsinos, and P. E. Vardas Effects of successful cardioversion of persistent atrial fibrillation on right ventricular refractoriness and repolarization Europace, January 1, 2005; 7(1): 34 - 39. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Ueda, D. P Zipes, and J. Wu Prior ischemia enhances arrhythmogenicity in isolated canine ventricular wedge model of long QT 3 Cardiovasc Res, July 1, 2004; 63(1): 69 - 76. [Abstract] [Full Text] [PDF] |
||||
![]() |
S.P Fynn, D.M Todd, W.J.C Hobbs, K.L Armstrong, and C.J Garratt Role of dispersion of atrial refractoriness in the recurrence of clinical atrial fibrillation. A manifestation of atrial electrical remodelling in humans? Eur. Heart J., October 1, 2001; 22(19): 1822 - 1834. [Abstract] [PDF] |
||||
![]() |
L. Polontchouk, J.-A. Haefliger, B. Ebelt, T. Schaefer, D. Stuhlmann, U. Mehlhorn, F. Kuhn-Regnier, E. R. De Vivie, and S. Dhein Effects of chronic atrial fibrillation on gap junction distribution in human and rat atria J. Am. Coll. Cardiol., September 1, 2001; 38(3): 883 - 891. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. H. Falk Atrial Fibrillation N. Engl. J. Med., April 5, 2001; 344(14): 1067 - 1078. [Full Text] [PDF] |
||||
![]() |
C Pandozi and M Santini Update on atrial remodelling owing to rate. Does atrial fibrillation always 'beget' atrial fibrillation? Eur. Heart J., April 1, 2001; 22(7): 541 - 553. [PDF] |
||||
![]() |
S. S. Chugh, J. L. Blackshear, W.-K. Shen, S. C. Hammill, and B. J. Gersh Epidemiology and natural history of atrial fibrillation: clinical implications J. Am. Coll. Cardiol., February 1, 2001; 37(2): 371 - 378. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Pandozi, L. Bianconi, L. Calo, A. Castro, F. Lamberti, M. C. Scianaro, G. Gentilucci, and M. Santini Postcardioversion atrial electrophysiologic changes induced by oral verapamil in patients with persistent atrial fibrillation J. Am. Coll. Cardiol., December 1, 2000; 36(7): 2234 - 2241. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. M.W. van der Velden, J. Ausma, M. B. Rook, A. J.C.G.M. Hellemons, T. A.A.B. van Veen, M. A. Allessie, and H. J. Jongsma Gap junctional remodeling in relation to stabilization of atrial fibrillation in the goat Cardiovasc Res, June 1, 2000; 46(3): 476 - 486. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. J. C. Hobbs, S. Fynn, D. M. Todd, P. Wolfson, M. Galloway, and C. J. Garratt Reversal of Atrial Electrical Remodeling After Cardioversion of Persistent Atrial Fibrillation in Humans Circulation, March 14, 2000; 101(10): 1145 - 1151. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. De Simone, G. Stabile, D. F. Vitale, P. Turco, M. Di Stasio, F. Petrazzuoli, M. Gasparini, C. De Matteis, R. Rotunno, and T. Di Napoli Pretreatment with verapamil in patients with persistent or chronic atrial fibrillation who underwent electrical cardioversion J. Am. Coll. Cardiol., September 1, 1999; 34(3): 810 - 814. [Abstract] [Full Text] [PDF] |
||||
![]() |
C.J. Meurling, M.P. Ingemansson, A. Roijer, J. Carlson, C.J. Lindholm, B. Smideberg, L. Sorno, M. Stridh, and S.B. Olsson Attenuation of electrical remodelling in chronic atrial fibrillation following oral treatment with verapamil Europace, January 1, 1999; 1(4): 234 - 241. [Abstract] [PDF] |
||||
![]() |
C. Pandozi, L. Bianconi, M. Villani, G. Gentilucci, A. Castro, G. Altamura, A. P. Jesi, F. Lamberti, F. Ammirati, and M. Santini Electrophysiological Characteristics of the Human Atria After Cardioversion of Persistent Atrial Fibrillation Circulation, December 22, 1998; 98(25): 2860 - 2865. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Fareh, C. Villemaire, and S. Nattel Importance of Refractoriness Heterogeneity in the Enhanced Vulnerability to Atrial Fibrillation Induction Caused by Tachycardia-Induced Atrial Electrical Remodeling Circulation, November 17, 1998; 98(20): 2202 - 2209. [Abstract] [Full Text] [PDF] |
||||
![]() |
M A Vos, S R Golitsyn, K Stangl, M Y Ruda, L Van Wijk, J D Harry, K T Perry, P Touboul, G Steinbeck, and H J J Wellens Superiority of ibutilide (a new class III agent) over DL-sotalol in converting atrial flutter and atrial fibrillation Heart, June 1, 1998; 79(6): 568 - 575. [Abstract] [Full Text] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1997 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |